Plasmapheresis
CRRT
- Features
- Performances
- Specifications
- References
- Julius et al.
- Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
- J Clin Apher. 22:215-23, 2007.
- Julius et al.
- The Dresden Apheresis Center - experience with LDL apheresis and immunoadsorption.
- Atheroscler Suppl.10:12-6,2009.
- Hovland et al.
- Patient tolerance regarding different low-density lipoprotein apheresis columns: frequent minor side effects and high patient satisfaction.
- J Clin Lipidol. 5:45-9,2011.
- Kamstrup et al.
- Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.
- Circulation.117:176-84,2008.
- Jaeger et al.
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events.
- Nat Clin Pract Cardiovasc Med.6:229-39,2009.
- Leebmann et al.
- Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)- hyper lipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.
- Circulation. 128: 2567-76,2013.
- Hirai et al.
- Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody- mediated rejection.
- Transpl Int.25:925-34,2012.
- Yamaji et al.
- Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
- Ther Apher Dial.12:298-305,2008.
- Liu et al.
- Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
- J Clin Apher. 26:174-80,2011.
- Kasuya et al.
- Clearance efficacy of autoantibodies in double filtration plasmapheresis for pemphigus foliaceus.
- Acta Derm Venereol.93:181-2,2013.
- Kitabata et al.
- Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report.
- Ther Apher. 5:484-90,2001.
- Weiss.
- A critical review on the use of lipid apheresis and rheopheresis for treatment of peripheral arterial disease and the diabetic foot syndrome.
- Semin Dial. 25:220-7,2012.
- Ferrannini et al.
- Rheopheresis in vascular diseases.
- Int J Artif Organs.30:923-9,2007.
- Klingel et al.
- Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.
- Ther Apher Dial.7:444-55,2003.
- Kim et al.
- Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis.
- Ther Apher Dial.17:631-7,2013.
- Isoda et al.
- Microscopic polyangiitis complicated with cerebral infarction and hemorrhage: a case report and review of literature.
- Nihon Rinsho Meneki Gakkai Kaishi.33:111-5,2010. JAPANESE
- Zhang et al.
- Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
- BMC Nephrol. 15:128,2014.
- Koss et al.
- Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART.
- Graefes Arch Clin Exp Ophthalmol. 247:1297-306, 2009.
Trademark
Cascadeflo is a trademark of Asahi Kasei Medical Co., Ltd.
Cascadeflo EC
Please feel free to send us any questions you may have about our products and support.
Share your feelings and experiences when using our products.
